Mere speculation?
About International Biotech Deal of the Year?
Your response defies logic. OBVIOUSLY that deal favours both parties....therefore it's not fanciful at all to assume that Teva will not "pour money" but in fact, support it's investment.
Both parties benefit.
The analysts get this, nobody is talking about MSB having funding issues except for you guys, trading the heck out if it. And scaring people needlessly.
You simply refuse to comprehend what the significance is of that deal.
We're onto you. Trader.
By MSB, page-124
-
- There are more pages in this discussion • 263 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
95.0¢ |
Change
0.025(2.70%) |
Mkt cap ! $1.084B | |||
| Open | High | Low | Value | Volume |
| 94.0¢ | 96.8¢ | 93.5¢ | $4.207M | 4.417M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 42268 | 94.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 95.0¢ | 48002 | 3 |
View Market Depth
| Last trade - 16.10pm 09/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |